Doctors at Al Qassimi Hospital in Sharjah, a flagship healthcare facility affiliated with Emirates Health Services (EHS), have achieved a historic milestone by successfully implanting the first dissolvable magnesium stent in the Middle East. This groundbreaking procedure, carried out on a 54-year-old Asian patient, not only signifies a remarkable advancement but also culminated in the patient's excellent recovery.
Doctors at Al Qassimi Hospital in Sharjah, one of the leading healthcare facilities under Emirates Health Services, conducted, for the first time in the Middle East, the implantation of the first resorbable magnesium Freesolve stent, for a 54-year-old Asian patient. The procedure was successful, and the patient was discharged in good condition.
Dr. Arif Al Nooryani, Director of Al Qassimi Hospital in Sharjah, emphasized that this achievement represents a revolution in the world of bioresorbable stents, noting that these stents are the latest of their kind and are being implanted for the first time in the Middle East with special specifications from BioTronik. They received European quality certification in February 2024. Dr. Al Nooryani emphasized the hospital's commitment to adopting cutting-edge technologies, such as the latest global stent advancements, to drive significant progress in medical care that prioritizes both effectiveness and safety. This progressive approach paves the way for innovative and secure cardiac treatment methods, enriching healthcare practices and resources. He also praised EHS for their dedication to equipping healthcare facilities with advanced medical technologies.
He elaborated that these stents offer an effective remedy for heart diseases like coronary artery disease by widening the arteries and improving blood flow to the heart. This reduces the risk of severe complications, enabling patients to restore their quality of life. Dr. Al Nooryani highlighted that the modern resorbable heart stents are highly effective in the long run, not only in reducing healthcare expenses but also in enhancing the outcomes of heart disease treatments.
These stents dissolve entirely over a period of 6 months to a year, disappearing without a trace. They stand out for preserving the flexibility of coronary arteries, improving blood flow, and maintaining the option to use the artery in future open-heart surgery if needed.